Perth life sciences player Syngenis Labs has joined forces with the renowned Perron Institute and the scientists behind Gene S to form a new precision-medicine company aimed at scaling an Australian-developed pharmacogenomics platform. Pharmacogenomics uses a patient’s genetic make-up to help determine which medicines and doses may work best for them.